DS
IBB icon

DRW Securities’s iShares Biotechnology ETF IBB Stock Holding History

DRW Securities’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41,139
Closed -$5.99M – 681
2024
Q3 		$5.99M Buy
+41,139
New +$5.95M 0.17% 77
2023
Q4 		– Sell
-3,879
Closed -$474K – 383
2023
Q3 		$474K Buy
3,879
+24
+0.6% +$3.05K 0.01% 222
2023
Q2 		$489K Sell
3,855
-26,695
-87% -$3.47M 0.01% 209
2023
Q1 		$3.95M Sell
30,550
-12,000
-28% -$1.57M 0.06% 78
2022
Q4 		$5.59M Buy
+42,550
New +$5.5M 0.15% 52

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DRW Securities's IBB Position: Q4 2024 in Review

DRW Securities sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 41,139 shares — an estimated $5.99M sold.

DRW Securities first reported a position in IBB in Q4 2022 and held it in 5 quarters. The position peaked at $5.99M in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • DRW Securities reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • DRW Securities sold 41,139 iShares Biotechnology ETF shares in Q4 2024, an estimated $5.99M.
  • DRW Securities first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 5 quarters.
  • DRW Securities's iShares Biotechnology ETF position peaked at $5.99M in Q3 2024.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on DRW Securities's 13F filing for Q4 2024, filed 13 Feb 2025.